Tag: CorWave

CorWave Strengthens Its Leadership Team with Two Key Appointments

CLICHY, France–(BUSINESS WIRE)–CorWave, a company pioneering innovative cardiac assist devices and currently conducting a clinical investigation following the first implantations of its undulating membrane heart pump, announces the appointments of Andreas Fleischli as Chief Technology Officer (CTO) and Daniel Lexcen as Vice President Clinical & Scientific Affairs. These strategic hires strengthen CorWave’s leadership team as the company prepares for the next stages of scaling its clinical

CorWave Announces Successful Completion of 6-Month Chronic In Vivo Study, Paving the Way for Clinical Trial Initiation

In vivo studies demonstrated the pump’s successful operation for a period of up to six months. Additionally, nine chronic ovine implants were conducted for 60 days with no device failure or sign of thrombosis at explant. These significant milestones mark the final stage of CorWave’s preclinical development, paving the way […]

CorWave Announces the Appointment of Fairuz Hasni as Vice President Human Resources

CLICHY, France–(BUSINESS WIRE)–CorWave, a French company that develops and manufactures innovative cardiac assist devices, announces the appointment of Fairuz Hasni as Vice President Human Resources. Fairuz Hasni has over twenty years of experience in industrial companies. She will support CorWave in the development of its HR functions and in its […]

CorWave Announces the Grand Opening of Its Manufacturing Facility on the Banks of the Seine, next to Paris

CLICHY, France–(BUSINESS WIRE)–CorWave, a French company that develops and manufactures innovative cardiac assist devices, held the grand opening of its new facility on the banks of the Seine in Clichy, next to Paris, on Monday, October 9th. The company occupies over 2,400m² of production, laboratory, and office space, bringing together […]

CorWave Announces Second Closing of Its Series C Funding at €61M to Finance Its First Industrial Deployment

CLICHY, France–(BUSINESS WIRE)–CorWave raised 61 million euros to fund its first industrial deployment and entry into clinical trials. SPI fund, managed by Bpifrance on behalf of the French Government as part of France 2030, and leading family controlled entrepreneurial groups were the main investors of this second closing. Founded in […]

CorWave Attracts Global Talent, Strengthening Its Management Team in Preparation for Clinical Phase and Industrial Ramp Up

CLICHY, France–(BUSINESS WIRE)–CorWave, a French medtech developing a next-generation heart pump, is recruiting top talent from throughout the world to strengthen its team. Two seasoned industry experts are joining the company: Paul Cornelison (USA) as Vice President, Regulatory Affairs, Quality Assurance and Clinical Affairs, and Michael Webb (Australia) as Vice […]

CorWave Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting

PARIS–(BUSINESS WIRE)–CorWave, a French medical device company committed to the fight against heart failure, announced that it has successfully completed the first 90-day preclinical study to evaluate its left ventricular assist device (LVAD) operating synchronously with the native heart without the use of sensors. The results were presented at the […]

CorWave Presents an Unprecedented Chronic In Vivo Study at the 41st Annual Meeting of the International Society of Heart and Lung Transplantation

CLICHY, France–(BUSINESS WIRE)–CorWave, a French medical device company committed to the fight against heart failure, unveiled an unprecedented study on the performance of its implantable heart pump at the 41st Annual Meeting of the International Society for Heart and Lung Transplantation (ISHLT). The company presented the first ever study demonstrating […]

CorWave Raises $40 Million in Series C Funding for Its Breakthrough Heart Pump

CLICHY, France–(BUSINESS WIRE)–CorWave reported today it has raised $40M from returning investors and three new investors. The company is developing an implantable heart pump (Left Ventricular Assist Device, LVAD) based on a breakthrough technology: the wave membrane pump. These new funds will enable CorWave to finalize development of its initial product, expand a […]